1. Home
  2. OTEX vs APLS Comparison

OTEX vs APLS Comparison

Compare OTEX & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Text Corporation

OTEX

Open Text Corporation

HOLD

Current Price

$23.42

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$40.86

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTEX
APLS
Founded
1991
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.2B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
OTEX
APLS
Price
$23.42
$40.86
Analyst Decision
Hold
Hold
Analyst Count
10
21
Target Price
$37.50
$32.71
AVG Volume (30 Days)
1.4M
8.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
4.76%
N/A
EPS Growth
N/A
112.50
EPS
1.24
0.20
Revenue
$2,815,241,000.00
$1,003,782,000.00
Revenue This Year
$2.82
N/A
Revenue Next Year
$1.04
$18.19
P/E Ratio
$18.65
$204.23
Revenue Growth
22.88
28.46
52 Week Low
$20.00
$16.10
52 Week High
$39.90
$40.88

Technical Indicators

Market Signals
Indicator
OTEX
APLS
Relative Strength Index (RSI) 55.33 87.61
Support Level $22.44 $18.53
Resistance Level $26.31 N/A
Average True Range (ATR) 0.91 0.20
MACD 0.27 0.69
Stochastic Oscillator 95.60 99.88

Price Performance

Historical Comparison
OTEX
APLS

About OTEX Open Text Corporation

Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).

Share on Social Networks: